379 filings
Page 6 of 19
8-K
snastiwzxls4 oxgogm
30 Mar 23
Avenue Therapeutics Reports Full Year 2022 Financial Results and Recent Corporate Highlights
4:07pm
8-K
q672vs9
8 Mar 23
Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates
4:10pm
8-K
hmudaiwg1m37exuhdtb
2 Mar 23
Entry into a Material Definitive Agreement
8:05am
SC 13G/A
xd8r4h4s9x0fdikypa9
14 Feb 23
AVENUE THERAPEUTICS / CVI Investments ownership change
11:22am
D
vcnk4tctzhet2p
14 Feb 23
$242.54 k in options, sold $242.54 k, 1 investor
9:15am
S-8
imji7rcq32
10 Feb 23
Registration of securities for employees
4:06pm
8-K
mfmuup0 zn7v1
10 Feb 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
jaguwv9 qrj99
3 Feb 23
Departure of Directors or Certain Officers
4:05pm
8-K
xkh2vn4g1prtqx47
1 Feb 23
Avenue Therapeutics Announces $3.25 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
8:15am
424B5
eisypov
31 Jan 23
Prospectus supplement for primary offering
12:05pm
8-K
0sqscp9wsrrm0118x
25 Jan 23
Changes in Registrant's Certifying Accountant
4:10pm
DEFA14A
dozfve6
17 Jan 23
Additional proxy soliciting materials
9:00am
SC 13D/A
m3bf dbi8
6 Jan 23
AVENUE THERAPEUTICS / Fortress Biotech ownership change
4:31pm
4
6julk3t199otpbxo
4 Jan 23
Change in insider ownership
5:49pm
DEFA14A
pwd790gvzqduc5 ux47
4 Jan 23
Additional proxy soliciting materials
11:01am
SC 13G
ftoo1vsbd pfph0r4
4 Jan 23
AVENUE THERAPEUTICS / SABBY MANAGEMENT ownership change
8:25am
SC 13G/A
cnfmts
14 Dec 22
AVENUE THERAPEUTICS / Nantahala Capital Management ownership change
4:06pm
DEFA14A
4ud2neno6rc
18 Nov 22
Additional proxy soliciting materials
4:30pm